Recent analyst actions
Fintel reports that on October 14, 2026, Canaccord Genuity initiated coverage of Amprius Technologies (NYSE:AMPX) with a Buy recommendation.
On the day of the initiation, Amprius Technologies closed at $7.98, down from $8.56 the previous session (October 13, 2026). Over the preceding week, the stock fell 14.42% from a close of $9.33 on October 7, 2026, and declined 12.92% from $9.17 one month earlier on September 14, 2026.
The consensus target price stood at $24.17 (mean) and $23.46 (median) as of October 2, 2026, implying a +202.74% upside from current levels. This reflects a downward revision from the prior mean target of $24.82 on September 15, 2026 (‑2.60%). As of September 1, 2026, analysts covering the stock numbered 17, with a breakdown of 4 strong buy, 12 buy, 1 hold, 0 sell, and 0 strong sell. The positive recommendation ratio was 94.1%, hold 5.9%, and negative 0.0%—identical to the prior period in August 2026.
Amprius Technologies reported earnings on August 4, 2026, posting an EPS of –$0.02 versus an estimate of –$0.0241, beating expectations. Quarterly revenue reached $34,032,000, exceeding the forecasted $29,885,816. The next earnings release is scheduled for November 5, 2026 (AMC session). HC Wainwright & Co. reiterated a Buy rating on September 29, 2026.
Recent analyst upgrades, downgrades, initiations, and maintained ratings. October 14, 2026 – Canaccord Genuity (Buy) initiated coverage. September 29, 2026 – HC Wainwright & Co. (Buy) reiterated its rating.
Also Read
- Anthropic reports 45% revenue jump as it gears up for IPO
- Saudi researchers launch landmark space mission to study aging and brain disorders
- Saudi Arabia Reiterates Commitment to Syria’s Reconstruction and Refugee Repatriation
- Russia and China Foreign Ministers Bolster Strategic Alliance Amid Regional Security Talks
